Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Related structures:
AlphaFold database: E9AEB1
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 16 |
GO:0006793 | phosphorus metabolic process | 3 | 16 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 16 |
GO:0006807 | nitrogen compound metabolic process | 2 | 16 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0009987 | cellular process | 1 | 16 |
GO:0016310 | phosphorylation | 5 | 16 |
GO:0019538 | protein metabolic process | 3 | 16 |
GO:0036211 | protein modification process | 4 | 16 |
GO:0043170 | macromolecule metabolic process | 3 | 16 |
GO:0043412 | macromolecule modification | 4 | 16 |
GO:0044237 | cellular metabolic process | 2 | 16 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 16 |
GO:0003824 | catalytic activity | 1 | 16 |
GO:0004672 | protein kinase activity | 3 | 16 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 6 |
GO:0005488 | binding | 1 | 16 |
GO:0005524 | ATP binding | 5 | 16 |
GO:0016301 | kinase activity | 4 | 16 |
GO:0016740 | transferase activity | 2 | 16 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 16 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 16 |
GO:0017076 | purine nucleotide binding | 4 | 16 |
GO:0030554 | adenyl nucleotide binding | 5 | 16 |
GO:0032553 | ribonucleotide binding | 3 | 16 |
GO:0032555 | purine ribonucleotide binding | 4 | 16 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 16 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 16 |
GO:0036094 | small molecule binding | 2 | 16 |
GO:0043167 | ion binding | 2 | 16 |
GO:0043168 | anion binding | 3 | 16 |
GO:0097159 | organic cyclic compound binding | 2 | 16 |
GO:0097367 | carbohydrate derivative binding | 2 | 16 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 16 |
GO:1901265 | nucleoside phosphate binding | 3 | 16 |
GO:1901363 | heterocyclic compound binding | 2 | 16 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.567 |
CLV_NRD_NRD_1 | 165 | 167 | PF00675 | 0.427 |
CLV_NRD_NRD_1 | 260 | 262 | PF00675 | 0.311 |
CLV_NRD_NRD_1 | 329 | 331 | PF00675 | 0.341 |
CLV_NRD_NRD_1 | 402 | 404 | PF00675 | 0.234 |
CLV_NRD_NRD_1 | 43 | 45 | PF00675 | 0.494 |
CLV_NRD_NRD_1 | 66 | 68 | PF00675 | 0.322 |
CLV_PCSK_FUR_1 | 64 | 68 | PF00082 | 0.310 |
CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.728 |
CLV_PCSK_KEX2_1 | 328 | 330 | PF00082 | 0.342 |
CLV_PCSK_KEX2_1 | 394 | 396 | PF00082 | 0.299 |
CLV_PCSK_KEX2_1 | 402 | 404 | PF00082 | 0.221 |
CLV_PCSK_KEX2_1 | 66 | 68 | PF00082 | 0.492 |
CLV_PCSK_PC1ET2_1 | 328 | 330 | PF00082 | 0.390 |
CLV_PCSK_PC1ET2_1 | 394 | 396 | PF00082 | 0.232 |
CLV_PCSK_SKI1_1 | 166 | 170 | PF00082 | 0.519 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.383 |
CLV_PCSK_SKI1_1 | 293 | 297 | PF00082 | 0.300 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.376 |
DOC_CYCLIN_RxL_1 | 161 | 172 | PF00134 | 0.512 |
DOC_MAPK_gen_1 | 259 | 269 | PF00069 | 0.388 |
DOC_MAPK_gen_1 | 293 | 303 | PF00069 | 0.322 |
DOC_MAPK_gen_1 | 44 | 51 | PF00069 | 0.327 |
DOC_MAPK_MEF2A_6 | 236 | 245 | PF00069 | 0.264 |
DOC_MAPK_MEF2A_6 | 268 | 276 | PF00069 | 0.247 |
DOC_MAPK_MEF2A_6 | 44 | 51 | PF00069 | 0.361 |
DOC_PP2B_LxvP_1 | 132 | 135 | PF13499 | 0.613 |
DOC_PP2B_LxvP_1 | 143 | 146 | PF13499 | 0.486 |
DOC_USP7_MATH_1 | 135 | 139 | PF00917 | 0.655 |
DOC_WW_Pin1_4 | 138 | 143 | PF00397 | 0.616 |
DOC_WW_Pin1_4 | 330 | 335 | PF00397 | 0.278 |
DOC_WW_Pin1_4 | 386 | 391 | PF00397 | 0.341 |
DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.466 |
LIG_14-3-3_CanoR_1 | 2 | 6 | PF00244 | 0.616 |
LIG_14-3-3_CanoR_1 | 261 | 269 | PF00244 | 0.375 |
LIG_14-3-3_CanoR_1 | 406 | 416 | PF00244 | 0.312 |
LIG_14-3-3_CanoR_1 | 428 | 433 | PF00244 | 0.304 |
LIG_14-3-3_CanoR_1 | 66 | 72 | PF00244 | 0.532 |
LIG_APCC_ABBAyCdc20_2 | 196 | 202 | PF00400 | 0.411 |
LIG_BRCT_BRCA1_1 | 409 | 413 | PF00533 | 0.339 |
LIG_Clathr_ClatBox_1 | 311 | 315 | PF01394 | 0.245 |
LIG_FHA_1 | 317 | 323 | PF00498 | 0.314 |
LIG_FHA_2 | 204 | 210 | PF00498 | 0.378 |
LIG_FHA_2 | 348 | 354 | PF00498 | 0.321 |
LIG_FHA_2 | 364 | 370 | PF00498 | 0.256 |
LIG_FHA_2 | 406 | 412 | PF00498 | 0.404 |
LIG_FHA_2 | 52 | 58 | PF00498 | 0.548 |
LIG_FHA_2 | 92 | 98 | PF00498 | 0.356 |
LIG_FXI_DFP_1 | 367 | 371 | PF00024 | 0.390 |
LIG_GBD_Chelix_1 | 272 | 280 | PF00786 | 0.305 |
LIG_LIR_Apic_2 | 335 | 341 | PF02991 | 0.268 |
LIG_LIR_Gen_1 | 410 | 421 | PF02991 | 0.339 |
LIG_LIR_Gen_1 | 6 | 15 | PF02991 | 0.428 |
LIG_LIR_Gen_1 | 75 | 85 | PF02991 | 0.360 |
LIG_LIR_Nem_3 | 163 | 168 | PF02991 | 0.391 |
LIG_LIR_Nem_3 | 369 | 373 | PF02991 | 0.237 |
LIG_LIR_Nem_3 | 410 | 416 | PF02991 | 0.362 |
LIG_LIR_Nem_3 | 6 | 11 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 70 | 74 | PF02991 | 0.418 |
LIG_SH2_CRK | 165 | 169 | PF00017 | 0.420 |
LIG_SH2_SRC | 229 | 232 | PF00017 | 0.306 |
LIG_SH2_STAP1 | 336 | 340 | PF00017 | 0.354 |
LIG_SH2_STAP1 | 409 | 413 | PF00017 | 0.260 |
LIG_SH2_STAT3 | 282 | 285 | PF00017 | 0.163 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.261 |
LIG_SH2_STAT5 | 282 | 285 | PF00017 | 0.255 |
LIG_SH2_STAT5 | 407 | 410 | PF00017 | 0.455 |
LIG_SH3_3 | 142 | 148 | PF00018 | 0.696 |
LIG_SH3_3 | 240 | 246 | PF00018 | 0.313 |
LIG_SH3_3 | 365 | 371 | PF00018 | 0.339 |
LIG_SH3_3 | 419 | 425 | PF00018 | 0.400 |
LIG_SUMO_SIM_anti_2 | 191 | 197 | PF11976 | 0.390 |
LIG_SUMO_SIM_anti_2 | 298 | 304 | PF11976 | 0.260 |
LIG_SUMO_SIM_anti_2 | 306 | 313 | PF11976 | 0.260 |
LIG_SUMO_SIM_par_1 | 191 | 197 | PF11976 | 0.390 |
LIG_TYR_ITIM | 227 | 232 | PF00017 | 0.243 |
LIG_TYR_ITIM | 69 | 74 | PF00017 | 0.359 |
LIG_WW_1 | 55 | 58 | PF00397 | 0.370 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.579 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.458 |
MOD_CK1_1 | 386 | 392 | PF00069 | 0.313 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.469 |
MOD_CK2_1 | 203 | 209 | PF00069 | 0.410 |
MOD_CK2_1 | 405 | 411 | PF00069 | 0.383 |
MOD_CK2_1 | 91 | 97 | PF00069 | 0.454 |
MOD_GlcNHglycan | 138 | 141 | PF01048 | 0.591 |
MOD_GlcNHglycan | 376 | 379 | PF01048 | 0.350 |
MOD_GlcNHglycan | 383 | 386 | PF01048 | 0.349 |
MOD_GlcNHglycan | 91 | 94 | PF01048 | 0.516 |
MOD_GSK3_1 | 316 | 323 | PF00069 | 0.286 |
MOD_GSK3_1 | 343 | 350 | PF00069 | 0.277 |
MOD_GSK3_1 | 85 | 92 | PF00069 | 0.404 |
MOD_N-GLC_1 | 200 | 205 | PF02516 | 0.390 |
MOD_N-GLC_1 | 320 | 325 | PF02516 | 0.163 |
MOD_N-GLC_2 | 23 | 25 | PF02516 | 0.348 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.559 |
MOD_NEK2_1 | 101 | 106 | PF00069 | 0.528 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.597 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.352 |
MOD_NEK2_1 | 316 | 321 | PF00069 | 0.163 |
MOD_NEK2_1 | 343 | 348 | PF00069 | 0.276 |
MOD_NEK2_1 | 381 | 386 | PF00069 | 0.343 |
MOD_PIKK_1 | 109 | 115 | PF00454 | 0.597 |
MOD_PIKK_1 | 34 | 40 | PF00454 | 0.455 |
MOD_PK_1 | 268 | 274 | PF00069 | 0.260 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.507 |
MOD_PKA_2 | 405 | 411 | PF00069 | 0.236 |
MOD_PKA_2 | 427 | 433 | PF00069 | 0.278 |
MOD_Plk_1 | 203 | 209 | PF00069 | 0.354 |
MOD_Plk_1 | 230 | 236 | PF00069 | 0.460 |
MOD_Plk_4 | 268 | 274 | PF00069 | 0.248 |
MOD_Plk_4 | 322 | 328 | PF00069 | 0.345 |
MOD_ProDKin_1 | 138 | 144 | PF00069 | 0.616 |
MOD_ProDKin_1 | 330 | 336 | PF00069 | 0.278 |
MOD_ProDKin_1 | 386 | 392 | PF00069 | 0.341 |
MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.477 |
MOD_SUMO_for_1 | 295 | 298 | PF00179 | 0.306 |
MOD_SUMO_rev_2 | 249 | 256 | PF00179 | 0.369 |
MOD_SUMO_rev_2 | 344 | 352 | PF00179 | 0.341 |
TRG_DiLeu_BaEn_1 | 298 | 303 | PF01217 | 0.284 |
TRG_DiLeu_BaEn_1 | 306 | 311 | PF01217 | 0.233 |
TRG_DiLeu_BaEn_1 | 412 | 417 | PF01217 | 0.310 |
TRG_ENDOCYTIC_2 | 165 | 168 | PF00928 | 0.395 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.260 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.438 |
TRG_ENDOCYTIC_2 | 8 | 11 | PF00928 | 0.417 |
TRG_ER_diArg_1 | 120 | 122 | PF00400 | 0.726 |
TRG_ER_diArg_1 | 401 | 403 | PF00400 | 0.247 |
TRG_ER_diArg_1 | 64 | 67 | PF00400 | 0.306 |
TRG_NES_CRM1_1 | 412 | 424 | PF08389 | 0.319 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HT76 | Leptomonas seymouri | 73% | 100% |
A0A0N1PCH4 | Leptomonas seymouri | 25% | 100% |
A0A0N1PE38 | Leptomonas seymouri | 32% | 67% |
A0A0S4IXR9 | Bodo saltans | 27% | 97% |
A0A0S4JWD5 | Bodo saltans | 28% | 100% |
A0A0S4JZV2 | Bodo saltans | 25% | 100% |
A0A1X0P1A2 | Trypanosomatidae | 24% | 98% |
A0A1X0P9C1 | Trypanosomatidae | 28% | 100% |
A0A1X0PA19 | Trypanosomatidae | 46% | 91% |
A0A3Q8IDY1 | Leishmania donovani | 97% | 100% |
A0A3R7K1T4 | Trypanosoma rangeli | 46% | 89% |
A0A3R7NGF4 | Trypanosoma rangeli | 28% | 80% |
A0A3S5H4Z4 | Leishmania donovani | 28% | 85% |
A0A3S7X2W9 | Leishmania donovani | 25% | 100% |
A0A3S7X7D5 | Leishmania donovani | 29% | 100% |
A0A422P2B2 | Trypanosoma rangeli | 27% | 98% |
A0A422P3P9 | Trypanosoma rangeli | 27% | 91% |
A4HHP8 | Leishmania braziliensis | 82% | 100% |
A4HHS9 | Leishmania braziliensis | 25% | 100% |
A4HRM6 | Leishmania infantum | 28% | 85% |
A4I4W3 | Leishmania infantum | 97% | 100% |
A4I4Y0 | Leishmania infantum | 25% | 100% |
A4I9H1 | Leishmania infantum | 29% | 100% |
C9ZKZ8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 96% |
C9ZW20 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 78% |
C9ZX15 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 24% | 90% |
E9AED4 | Leishmania major | 24% | 100% |
E9AJJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 84% |
E9AKG1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
E9ALF2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9ALH5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
E9B4G9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
O04086 | Arabidopsis thaliana | 26% | 72% |
O35831 | Rattus norvegicus | 26% | 86% |
Q15131 | Homo sapiens | 26% | 100% |
Q2TBL8 | Bos taurus | 26% | 100% |
Q2V419 | Arabidopsis thaliana | 26% | 100% |
Q3UMM4 | Mus musculus | 27% | 100% |
Q52WX2 | Homo sapiens | 28% | 100% |
Q6GPL3 | Xenopus laevis | 25% | 100% |
Q8K0D0 | Mus musculus | 26% | 86% |
Q8LF80 | Arabidopsis thaliana | 26% | 100% |
Q8QZX0 | Mus musculus | 28% | 100% |
Q924X7 | Mus musculus | 26% | 92% |
Q9NI63 | Drosophila melanogaster | 26% | 85% |
Q9SII6 | Arabidopsis thaliana | 26% | 100% |
Q9STF0 | Arabidopsis thaliana | 29% | 100% |
Q9U2Q9 | Caenorhabditis elegans | 26% | 100% |
Q9VT57 | Drosophila melanogaster | 26% | 99% |
Q9Z335 | Rattus norvegicus | 28% | 100% |
V5BJT8 | Trypanosoma cruzi | 31% | 100% |
V5BPJ0 | Trypanosoma cruzi | 26% | 91% |
V5BSK0 | Trypanosoma cruzi | 49% | 91% |
V5CI11 | Trypanosoma cruzi | 27% | 94% |